CMV

COMMUNIQUÉS West-GlobeNewswire

Positron Corporation Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group
13/08/2025
Niagara Falls, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64- [...]
Natural Weight Loss Supplements: How PhenQ Became the Leading Alternative to Anti-Obesity Injections in 2025
13/08/2025
London, UK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PhenQ leads 2025 with a multi-action, science-informed approach to weight loss - no needles, no prescriptions, just clean, sustainable natural weight management that fits [...]
Muscular Endurance: Bodybuilders Choose CrazyBulk Bodybuilding Supplements For Peak Performance & Strength Building
13/08/2025
Discover how CrazyBulk’s legal bodybuilding supplements can enhance muscular endurance, boost strength, and speed up recovery. Learn optimal stacks, training integration tips, and where to buy authentic CrazyBulk [...]
Erdem Hospital Performs First-of-Its-Kind Spinal Revision Surgery
13/08/2025
Groundbreaking procedure restores mobility to Italian patient after years of paralysis Photo: Erdem Hospital via FL Communications ISTANBUL, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Erdem Hospital has announced the successful [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2025
13/08/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2025 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l' [...]
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
13/08/2025
ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that [...]
Inotiv, Inc. to Participate in Three Investor Conferences in September 2025
13/08/2025
WEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and [...]
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
13/08/2025
BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today closed an upsized private placement of 11,040, [...]
Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights
13/08/2025
– Reported positive topline results from the ongoing Phase 2 TRANQUILITY trial of pacibekitug in May 2025, demonstrating rapid, deep, and durable reductions in high-sensitivity C-reactive protein with quarterly dosing [...]
American Shared Hospital Services Reports Second Quarter 2025 Financial Results
13/08/2025
Total Revenue Increased 16% Sequentially Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading [...]
Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights
13/08/2025
Continued Clinical Program Execution in the Phase 3 CoMpass Trial in Early Choroidal Melanoma and the Phase 1b/2 Trial in Non-Muscle Invasive Bladder Cancer (NMIBC) Strengthened Balance Sheet with $75 Million Equity [...]
Immatics Announces Second Quarter 2025 Financial Results and Business Update
13/08/2025
Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: One-time infusion continues to show favorable tolerability as well as strong anti-tumor activity and durability in 33 heavily pretreated patients with [...]
On World Organ Donation Day KFSHRC Announces 10 Kidney Exchange Transplants Completed in 48 Hours
13/08/2025
RIYADH, Saudi Arabia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) successfully performed 10 kidney exchange transplants over two consecutive days, setting a global [...]
LIXTE Biotechnology Holdings Updates Corporate Treasury Policy to Include Cryptocurrency
13/08/2025
PASADENA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) ( Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that its Board of [...]
XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
13/08/2025
Business development : Purchased mezagitamab royalty and milestone rights held by BioInvent International and will secure royalty economic interests in two early-stage partnered assets through XOMA Royalty’s recently [...]
Sagimet Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
13/08/2025
Denifanstat met all primary and secondary endpoints in Phase 3 clinical trial in moderate to severe acne conducted by license partner Ascletis in China Initiated first-in-human Phase 1 clinical trial of FASN inhibitor [...]
Nasus Pharma Announces Pricing of $10 Million Initial Public Offering
13/08/2025
TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products [...]
BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights
13/08/2025
Achieved record quarterly revenue of $12.6 million in Q2 2025, an increase of 26% compared to Q2 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.5 million, Raised full-year 2025 Revenue and [...]
PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results
13/08/2025
Positive Phase 3 SHIELD II Trial Results - D-PLEX₁₀₀ successfully met its primary efficacy endpoint and demonstrated 58% reduction in SSI NDA submission expected in Q1 2026 Unveil ed a Long-Acting GLP-1 Receptor [...]

Pages